BioTech

Biotech Losers: Aegerion Pharmaceuticals (NASDAQ:AEGR), Ocera Therapeutics (NASDAQ:OCRX), Onconova Therapeutics (NASDAQ:ONTX), CYANOTECH (NASDAQ:CYAN)

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was a big mover last session, as its shares rose nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the trend for the healthcare company since Feb 24, as the stock is now down nearly 19%.stock performance was -7.00% in last session and finished the day at $48.79. Traded volume was 1,457,055 million shares in the last session and the average volume 12.63 of the stock remained 856.98 million shares. The beta of the stock remained 1.12. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) insider ownership is 12.63%.

Ocera Therapeutics, Inc. (NASDAQ:OCRX) presented at the Cowen and Company 34th Annual Health Care Conference.Ocera Therapeutics Inc (NASDAQ:OCRX) dropped -8.19 percent to $14.13 yesterday on volume of 100,319.00 million shares. The intra-day range of the stock was $14.01 to $16.92. Ocera Therapeutics Inc (NASDAQ:OCRX) has a market capitalization of $215.23 million.

Onconova Therapeutics (NASDAQ:ONTX)’s share price shot up 4.4% during mid-day trading on Monday following a better than expected earnings announcement,AnalystRatingsNetwork reports. Onconova Therapeutics Inc (NASDAQ:ONTX)’s stock on Mar 11, 2014 reported a decrease of -8.71% to the closing price of $7.44. Its fifty two weeks range is $7.02 -$31.13. The total market capitalization recorded $159.30 million. The overall volume in the last trading session was 852,175 million shares. In its share capital, Onconova Therapeutics Inc (NASDAQ:ONTX) has 15.48 million outstanding shares.

Cyanotech Corporation (NASDAQ:CYAN) produces natural products derived from microalgae. Cyanotech is engaged in the cultivation and production of microalgae into natural health and nutrition products. The Company cultivates two microalgal species from, which its two major product lines, spirulina products and natural astaxanthin products, are derived. On Tuesday, shares of CYANOTECH CORP (NASDAQ:CYAN) dropped -12.24% to close the day at $5.52. Company return on investment (ROI) is 16.70% and its monthly performance is recorded as 6.15%. CYANOTECH CORP (NASDAQ:CYAN) quarterly revenue growth is 13.35%.